These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20553775)

  • 1. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.
    Lee J; Oh YJ; Lee SK; Lee KY
    J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
    Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
    J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of protein delivery from modular polymer scaffolds.
    Lee M; Chen TT; Iruela-Arispe ML; Wu BM; Dunn JC
    Biomaterials; 2007 Apr; 28(10):1862-70. PubMed ID: 17184836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-step modified method to reduce the burst initial release from PLGA microspheres.
    Zheng C; Liang W
    Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
    Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controllable promotion of chondrocyte adhesion and growth on PVA hydrogels by controlled release of TGF-β1 from porous PLGA microspheres.
    Nie L; Zhang G; Hou R; Xu H; Li Y; Fu J
    Colloids Surf B Biointerfaces; 2015 Jan; 125():51-7. PubMed ID: 25437063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entrapment of protein using electrosprayed poly(D,L-lactide-co-glycolide) microspheres with a porous structure for sustained release.
    Paik DH; Choi SW
    Macromol Rapid Commun; 2014 Jun; 35(11):1033-8. PubMed ID: 24700776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
    Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
    J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of temperature-sensitive poly(N-isopropylacrylamide)-b-poly(D,L-lactide) microspheres for protein delivery.
    Liu SQ; Yang YY; Liu XM; Tong YW
    Biomacromolecules; 2003; 4(6):1784-93. PubMed ID: 14606909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
    Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
    J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.